Literature DB >> 12626323

Glucagon and regulation of glucose metabolism.

Guoqiang Jiang1, Bei B Zhang.   

Abstract

As a counterregulatory hormone for insulin, glucagon plays a critical role in maintaining glucose homeostasis in vivo in both animals and humans. To increase blood glucose, glucagon promotes hepatic glucose output by increasing glycogenolysis and gluconeogenesis and by decreasing glycogenesis and glycolysis in a concerted fashion via multiple mechanisms. Compared with healthy subjects, diabetic patients and animals have abnormal secretion of not only insulin but also glucagon. Hyperglucagonemia and altered insulin-to-glucagon ratios play important roles in initiating and maintaining pathological hyperglycemic states. Not surprisingly, glucagon and glucagon receptor have been pursued extensively in recent years as potential targets for the therapeutic treatment of diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626323     DOI: 10.1152/ajpendo.00492.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  222 in total

Review 1.  Regulation of metabolism: the circadian clock dictates the time.

Authors:  Saurabh Sahar; Paolo Sassone-Corsi
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

2.  Hydrogen exchange mass spectrometry as an analytical tool for the analysis of amyloid fibrillogenesis.

Authors:  Carsten Scavenius; Shirin Ghodke; Daniel E Otzen; Jan J Enghild
Journal:  Int J Mass Spectrom       Date:  2011-04-30       Impact factor: 1.986

Review 3.  Minireview: Glucagon in stress and energy homeostasis.

Authors:  B J Jones; T Tan; S R Bloom
Journal:  Endocrinology       Date:  2012-01-31       Impact factor: 4.736

Review 4.  The nature of amyloid-like glucagon fibrils.

Authors:  Jesper Søndergaard Pedersen
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

5.  A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.

Authors:  Jianxin Hu; Matthew Stern; Luis E Gimenez; Lizzy Wanka; Lu Zhu; Mario Rossi; Jaroslawna Meister; Asuka Inoue; Annette G Beck-Sickinger; Vsevolod V Gurevich; Jürgen Wess
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

Review 6.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

7.  Calcium-mediated signaling and calmodulin-dependent kinase regulate hepatocyte-inducible nitric oxide synthase expression.

Authors:  Baochun Zhang; Will Crankshaw; Ryan Nesemeier; Jay Patel; Ikenna Nweze; Jaganathan Lakshmanan; Brian G Harbrecht
Journal:  J Surg Res       Date:  2014-07-24       Impact factor: 2.192

8.  Glucagon activates Ca2+ and Cl- channels in rat hepatocytes.

Authors:  Edoardo C Aromataris; Michael L Roberts; Greg J Barritt; Grigori Y Rychkov
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

9.  Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.

Authors:  M Sörhede Winzell; C L Brand; N Wierup; U G Sidelmann; F Sundler; E Nishimura; B Ahrén
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

10.  Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis.

Authors:  Eva Tomas; Joel F Habener
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.